NM_001006997 // GO:0006685 // sphingomyelin catabolic process // inferred from electronic annotation  /// NM_001006997 // GO:0023021 // termination of signal transduction // inferred from electronic annotation  /// NM_001006997 // GO:0023021 // termination of signal transduction // not recorded  /// NM_001006997 // GO:0035307 // positive regulation of protein dephosphorylation // inferred from electronic annotation  /// NM_001006997 // GO:0035307 // positive regulation of protein dephosphorylation // not recorded  /// NM_001006997 // GO:0042220 // response to cocaine // inferred from direct assay  /// NM_001006997 // GO:0042493 // response to drug // inferred from expression pattern  /// NM_001006997 // GO:0043065 // positive regulation of apoptotic process // inferred from mutant phenotype  /// NM_001006997 // GO:0043407 // negative regulation of MAP kinase activity // inferred from electronic annotation  /// NM_001006997 // GO:0043407 // negative regulation of MAP kinase activity // not recorded  /// NM_001006997 // GO:0046513 // ceramide biosynthetic process // inferred from mutant phenotype  /// NM_001006997 // GO:0046513 // ceramide biosynthetic process // not recorded  /// ENSRNOT00000024224 // GO:0006685 // sphingomyelin catabolic process // inferred from electronic annotation  /// ENSRNOT00000024224 // GO:0023021 // termination of signal transduction // inferred from electronic annotation  /// ENSRNOT00000024224 // GO:0023021 // termination of signal transduction // not recorded  /// ENSRNOT00000024224 // GO:0035307 // positive regulation of protein dephosphorylation // inferred from electronic annotation  /// ENSRNOT00000024224 // GO:0035307 // positive regulation of protein dephosphorylation // not recorded  /// ENSRNOT00000024224 // GO:0042220 // response to cocaine // inferred from direct assay  /// ENSRNOT00000024224 // GO:0042493 // response to drug // inferred from expression pattern  /// ENSRNOT00000024224 // GO:0043065 // positive regulation of apoptotic process // inferred from mutant phenotype  /// ENSRNOT00000024224 // GO:0043407 // negative regulation of MAP kinase activity // inferred from electronic annotation  /// ENSRNOT00000024224 // GO:0043407 // negative regulation of MAP kinase activity // not recorded  /// ENSRNOT00000024224 // GO:0046513 // ceramide biosynthetic process // inferred from mutant phenotype  /// ENSRNOT00000024224 // GO:0046513 // ceramide biosynthetic process // not recorded  /// BC083780 // GO:0006685 // sphingomyelin catabolic process // inferred from electronic annotation  /// BC083780 // GO:0023021 // termination of signal transduction // inferred from electronic annotation  /// BC083780 // GO:0023021 // termination of signal transduction // not recorded  /// BC083780 // GO:0035307 // positive regulation of protein dephosphorylation // inferred from electronic annotation  /// BC083780 // GO:0035307 // positive regulation of protein dephosphorylation // not recorded  /// BC083780 // GO:0042220 // response to cocaine // inferred from direct assay  /// BC083780 // GO:0042493 // response to drug // inferred from expression pattern  /// BC083780 // GO:0043065 // positive regulation of apoptotic process // inferred from mutant phenotype  /// BC083780 // GO:0043407 // negative regulation of MAP kinase activity // inferred from electronic annotation  /// BC083780 // GO:0043407 // negative regulation of MAP kinase activity // not recorded  /// BC083780 // GO:0046513 // ceramide biosynthetic process // inferred from mutant phenotype  /// BC083780 // GO:0046513 // ceramide biosynthetic process // not recorded